CN104208643A - Chinese medicine for treating hemiplegia and preparation method thereof - Google Patents
Chinese medicine for treating hemiplegia and preparation method thereof Download PDFInfo
- Publication number
- CN104208643A CN104208643A CN201410495980.7A CN201410495980A CN104208643A CN 104208643 A CN104208643 A CN 104208643A CN 201410495980 A CN201410495980 A CN 201410495980A CN 104208643 A CN104208643 A CN 104208643A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- rhizoma
- chinese medicine
- hemiplegia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Chinese medicine for treating hemiplegia and a preparation method thereof. The Chinese medicine is prepared by the following raw materials of ginseng, milkvetch roots, Chinese angelica, white paeony roots, Indian buead, bighead atractylodes rhizome, liquorice roots, prepared rehmannia roots, Sichuan lovage rhizome, cassia barks, pinellia ternate, radix aconiti kusnezoffii preparata, malaytea scurfpea fruit, dwarf lilyturf tuber, villous amomum fruit, tree peony barks, Chinese thorowax roots, ginger juice, rhizoma arisaematis, grassleaf sweetflag rhizome, date seeds, dried tangerine or orange peel, combined spicebush roots, radix stephaniae tetrandrae, costus roots, and agilawood. The raw materials are decocted, filtered, concentrated, immersed, dried, and crushed to obtain the Chinese medicine. The Chinese medicine is capable of radically nursing interior mechanisms of bodies and effectively treating hemiplegia, complications of hemiplegia, and sequelae, and is innovative medicine for treating hemiplegia.
Description
Technical field
The invention belongs to field of medicaments, especially a kind of Chinese medicine for the treatment of hemiplegia and preparation method thereof.
Background technology
Hemiplegia (also known as hemiplegia), refer to the dyskinesia of side upper and lower extremities, facial muscle and lingualis bottom, it is a common sympton of acute cerebrovascular disease, because its early symptom is not obvious, be easy to be ignored by people, cause falling in a swoon suddenly, unconscious, hemiplegia, facial hemiparalysis, speech tremble with fear the clinical manifestation such as puckery.This disease is many to be caused by emotional maladjustment, improper diet, the reason such as to overwork, more difficult prevention.
In recent years, the hemiplegia patient that the various cause of disease causes sharply increases, and treatment is got up, not only costly, and is difficult to radical cure, then causes function to worsen, brings heavy economy and stress to patient and household.
In addition, during hemiplegia morbidity, how without reason body falls, shudders with fear, aphasia, hands are inactive, failure of the lower limbs to walk, expectorant sound are as active in snore, only binocular, often being missed disease is simple expectorant disease, in fact, this symptom is the compound of phlegm syndrome and apoplexy, all cannot be effected a radical cure merely by apoplexy or phlegm syndrome.
Summary of the invention
The invention discloses a kind of Chinese medicine for the treatment of hemiplegia and preparation method thereof, this Chinese medicine adopts brand-new Chinese medicine formula, there is refreshment of reducing phlegm, dispelling, collateral-activating, effective treatment is fallen in a swoon suddenly, unconscious, hemiplegia, facial hemiparalysis, speech tremble with fear sequela that is puckery and that cause.
The technical solution used in the present invention is: the medicament be made up of the raw material of following weight proportion, Radix Ginseng 20-40 part, Radix Astragali 40-60 part, Radix Angelicae Sinensis 10-20 part, Radix Paeoniae Alba 10-20 part, Poria 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Radix Glycyrrhizae 3-7 part, Radix Rehmanniae Preparata 40-60 part, Rhizoma Chuanxiong 10-20 part, Cortex Cinnamomi 8-12 part, Rhizoma Pinelliae 8-12 part, Radix Aconiti Lateralis Preparata 8-12 part, Fructus Psoraleae 3-7 part, Radix Ophiopogonis 40-60 part, Fructus Amomi 8-12 part, Cortex Moutan 10-20 part, Radix Bupleuri 5-15 part, Sucus Zingberis 10-20 part, Rhizoma Arisaematis 8-12 part, save prosperous fore-telling 5-15 part, Semen Ziziphi Spinosae 10-20 part, Pericarpium Citri Reticulatae 5-15 part, Radix Linderae 5-15 part, Radix Stephaniae Tetrandrae 3-7 part, Radix Aucklandiae (Radix Vladimiriae) 5-15 part, Lignum Aquilariae Resinatum 8-12 part is made.
As a kind of preferred implementation, the medicament be made up of the raw material of following weight proportion: Radix Ginseng 25-35 part, Radix Astragali 45-55 part, Radix Angelicae Sinensis 12-18 part, Radix Paeoniae Alba 12-18 part, Poria 23-27 part, Rhizoma Atractylodis Macrocephalae 23-27 part, Radix Glycyrrhizae 4-6 part, Radix Rehmanniae Preparata 45-55 part, Rhizoma Chuanxiong 12-18 part, Cortex Cinnamomi 9-11 part, Rhizoma Pinelliae 9-11 part, Radix Aconiti Lateralis Preparata 9-11 part, Fructus Psoraleae 4-6 part, Radix Ophiopogonis 45-55 part, Fructus Amomi 9-11 part, Cortex Moutan 13-17 part, Radix Bupleuri 8-12 part, Sucus Zingberis 12-18 part, Rhizoma Arisaematis 9-11 part, save prosperous fore-telling 8-12 part, Semen Ziziphi Spinosae 12-18 part, Pericarpium Citri Reticulatae 7-13 part, Radix Linderae 7-13 part, Radix Stephaniae Tetrandrae 4-6 part, Radix Aucklandiae (Radix Vladimiriae) 7-13 part, Lignum Aquilariae Resinatum 9-11 part is made.
As a kind of preferred implementation, the medicament be made up of the raw material of following weight proportion: Radix Ginseng 30 parts, the Radix Astragali 50 parts, Radix Angelicae Sinensis 15 parts, the Radix Paeoniae Alba 15 parts, 25 parts, Poria, the Rhizoma Atractylodis Macrocephalae 25 parts, 5 parts, Radix Glycyrrhizae, 50 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 15 parts, Cortex Cinnamomi 10 parts, the Rhizoma Pinelliae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, Fructus Psoraleae 5 parts, Radix Ophiopogonis 50 parts, Fructus Amomi 10 parts, Cortex Moutan 15 parts, Radix Bupleuri 10 parts, Sucus Zingberis 15 parts, Rhizoma Arisaematis 10 parts, save prosperous fore-telling 10 parts, Semen Ziziphi Spinosae 15 parts, Pericarpium Citri Reticulatae 10 parts, the Radix Linderae 10 parts, Radix Stephaniae Tetrandrae 5 parts, Radix Aucklandiae (Radix Vladimiriae) 10 parts, Lignum Aquilariae Resinatum 10 parts make.
As a kind of preferred implementation, above-mentioned medicament is said dosage form on any one pharmaceutics, and preferably, described medicament is powder or block agent.
The production method that above-mentioned each component makes Chinese medicine of the present invention is made: first by the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, save prosperous fore-telling, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum mixes by part, add water and decoct 2-4 time, decoct 1-3h at every turn, the decocting liquid of difference gained is merged, filter, be concentrated into the thick paste that relative density is 1.2-2, add Radix Ginseng again, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae soaks, dry, be crushed to granularity and be no more than 400 object powders.
As the preferred implementation method of one, first the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, the prosperous fore-telling of joint, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum are mixed by part, add water and decoct 3 times, decoct 2h at every turn, the decocting liquid of gained is respectively merged, filters, is concentrated into the thick paste that relative density is 1.3-1.9, then add Radix Ginseng, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae carry out immersion 0.5h-2h, dry, be crushed to granularity is no more than 400 object powders.
Certain technique scheme is also direct to be taken by soaking, drying, pulverize the powder obtained, and also in order to taking convenience, then powder can be processed into the forms such as pill, tablet, powder, capsule.
The present invention defers to the compatibility mechanism of monarch, wherein, monarch drug has the Radix Astragali, Radix Rehmanniae Preparata, Radix Ophiopogonis, Radix Ginseng, ministerial drug has Poria, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Cortex Moutan, Sucus Zingberis, Semen Ziziphi Spinosae, make medicine be Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Amomi, Radix Bupleuri, Rhizoma Arisaematis, the prosperous fore-telling of joint, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum, make medicine be Radix Glycyrrhizae, Fructus Psoraleae, Radix Stephaniae Tetrandrae.
The Radix Astragali in monarch drug, Radix Ginseng, Radix Ophiopogonis returns lung meridian, Radix Rehmanniae Preparata returns liver, kidney channel, hemiplegia is many to be occurred with phlegm syndrome, and expectorant is at lung, mostly be dryness-fire, and lung not moisture-proof, also not resistance to dry, need with the flat Radix Ginseng of property, the Radix Astragali warm in nature, the Radix Ophiopogonis of cold nature, make lung cold not hot, damping is adjusted dry, add nourishing YIN and supplementing blood, benefit essence fills out the Radix Rehmanniae Preparata of marrow, vital essence replenishing, the dryness of the lung must be moistened, asthenic fire must be held back, make dry phlegm from changing, Radix Ginseng strongly invigorating primordial QI simultaneously, multiple arteries and veins takes off admittedly, invigorating the spleen to benefit the lung, promote the production of body fluid, Radix Astragali invigorating QI to consolidate the body surface resistance, Radix Rehmanniae Preparata nourishing YIN and supplementing blood, benefit essence fills out marrow, Radix Ophiopogonis YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire, four taste monarchs drug are effectively nursed one's health hemiplegia, play primary treatment effect.Poria in ministerial drug, the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Cortex Moutan, Sucus Zingberis, Semen Ziziphi Spinosae 8 taste Chinese medicine, consideration consumption makes ministerial drug also for property is put down, have promoting diuresis to eliminate damp pathogen, invigorating the spleen and benefiting QI concurrently, enrich blood invigorate blood circulation, the effect such as blood-activating and qi-promoting, blood circulation promoting and blood stasis dispelling, coordinate the primary symptom of monarch drug treatment hemiplegia.The Rhizoma Pinelliae in adjuvant drug, Radix Aconiti Lateralis Preparata, Fructus Amomi, Rhizoma Arisaematis, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Aucklandiae (Radix Vladimiriae) play drying dampness to eliminate phlegm, by wind-cold damp pathogen, removing dampness circulation of qi promoting, expelling wind and relieving convulsion, circulation of qi promoting cold expelling, pain relieving effect, coordinate monarch, ministerial drug reinforcement therapeutical effect, and Cortex Cinnamomi in adjuvant drug, Radix Bupleuri, the prosperous fore-telling of joint, Lignum Aquilariae Resinatum have and mend that fire is supporing yang, effect of warming the meridian and promoting blood circulation, reconciling superficies and interior, warming spleen and stomach for dispelling cold, contrary with monarch drug nature and flavor, strong for what slow down in monarch, ministerial drug.Make the Radix Glycyrrhizae in medicine, Fructus Psoraleae, Radix Stephaniae Tetrandrae, although consumption is very little, there is coordinating the actions of various ingredients in a prescription, effect of dredging kidney, spleen, stomach, lung, bladder pericardium meridians, monarch, minister, adjuvant drug arrival focus can be drawn.Monarch, minister in this Chinese medicine, help, medicine is cooperatively interacted coordination, mutually support, by conditioning human body environment, strengthen autoimmune function, reach effect of radical cure hemiplegia and complication thereof.
Abundant raw material of the present invention, safe and reliable, good effect, be that treatment hemiplegia, speech are trembled with fear the brand-new Chinese medicine formula of the hemiplegia complication such as puckery, facial hemiparalysis, taking convenience, the course for the treatment of is shorter, evident in efficacy.
Detailed description of the invention
Below in conjunction with embodiment, the specific embodiment of the present invention is described in further detail.
Embodiment 1.
Treat a Chinese medicine for hemiplegia, the medicament be made up of the raw material of following weight proportion: Radix Ginseng 30g, Radix Astragali 50g, Radix Angelicae Sinensis 15g, Radix Paeoniae Alba 15g, Poria 25g, Rhizoma Atractylodis Macrocephalae 25g, Radix Glycyrrhizae 5g, Radix Rehmanniae Preparata 50g, Rhizoma Chuanxiong 15g, Cortex Cinnamomi 10g, Rhizoma Pinelliae 10g, Radix Aconiti Lateralis Preparata 10g, Fructus Psoraleae 5g, Radix Ophiopogonis 50g, Fructus Amomi 10g, Cortex Moutan 15g, Radix Bupleuri 10g, Sucus Zingberis 15g, Rhizoma Arisaematis 10g, save prosperous fore-telling 10g, Semen Ziziphi Spinosae 15g, Pericarpium Citri Reticulatae 10g, Radix Linderae 10g, Radix Stephaniae Tetrandrae 5g, Radix Aucklandiae (Radix Vladimiriae) 10g, Lignum Aquilariae Resinatum 10g makes, wherein, by the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, save prosperous fore-telling, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum mixes, and adds 100g decocting and endures 3 times, decoct 2h at every turn, is merged by the decocting liquid of difference gained, filter, be concentrated into the thick paste that relative density is 1.5, then add Radix Ginseng, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae carries out immersion 1h, dry, grinding particle size is 320 object powders, incapsulates in shell, makes Chinese medicinal capsule.
Embodiment 2.
Treat a Chinese medicine for hemiplegia, the medicament be made up of the raw material of following weight proportion: Radix Ginseng 27g, Radix Astragali 48g, Radix Angelicae Sinensis 16g, Radix Paeoniae Alba 17g, Poria 24g, Rhizoma Atractylodis Macrocephalae 26g, Radix Glycyrrhizae 5g, Radix Rehmanniae Preparata 49g, Rhizoma Chuanxiong 14g, Cortex Cinnamomi 10g, Rhizoma Pinelliae 11g, Radix Aconiti Lateralis Preparata 9g, Fructus Psoraleae 5g, Radix Ophiopogonis 52g, Fructus Amomi 11g, Cortex Moutan 16g, Radix Bupleuri 9g, Sucus Zingberis 16g, Rhizoma Arisaematis 9g, save prosperous fore-telling 11g, Semen Ziziphi Spinosae 14g, Pericarpium Citri Reticulatae 16g, Radix Linderae 11g, Radix Stephaniae Tetrandrae 6g, Radix Aucklandiae (Radix Vladimiriae) 11g, Lignum Aquilariae Resinatum 9g makes, wherein, by the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, save prosperous fore-telling, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum mixes, and adds 1200g decocting and endures 3 times, decoct 2.5h at every turn, is merged by the decocting liquid of difference gained, filter, be concentrated into the thick paste that relative density is 1.4, then add Radix Ginseng, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae carries out immersion 0.8h, dry, being ground into granularity is 280 object powders, reinstalls in capsule shells, makes Chinese medicinal capsule.
1 case-data.
Observe case totally 100 examples, patient is outpatient service and the admissions office patient of certain academy of traditional Chinese medicine, and single-blind randomized is divided into treatment group and matched group 2 groups, often organizes each 50 examples.In treatment group man 35 example, female 15 example, age 40-80 year, the mean age is 63.2 years old, the course of disease 3 days-10 months, average 2.5 months.In matched group man 31 example, female 19 example, age 40-80 year, the mean age is 63.7 years old, the course of disease 3 days-10 months, average 2.7 months.Two groups are compared at sex, age, the course of disease, coincident with severity degree of condition and accompanying diseases etc., and no significant difference (P >=0.05), has comparability.
2 Therapeutic Method.
2.1 matched groups give western medicine routine treatment; because doctor trained in Western medicine claims hemiplegia to be apoplexy sequela; therefore employing brain is protected, improved the measure such as cerebral circulation, trophic nerve, accompanied with hypertension, diabetes, coronary disease patient give blood pressure lowering, control the process such as blood glucose and coronary dilating.Ischemic Stroke adds antiplatelet aggregation, anticoagulant therapy.
2.2 treatment groups coordinate Chinese medicinal capsule of the present invention on matched group basis.3 times on the one, a 2-5 grain, 10 days is a course for the treatment of, takes and can take effect 3-10 the course for the treatment of, and consumption can make the appropriate adjustments according to patient age, body weight, the type and the order of severity etc. of disease for the treatment of.
3 observation index.
3.1 curative effect index patient subjective symptomss, record respectively to the symptom before and after patient treatment, pass judgment on therapeutic effect according to criterion of cure, effectively standard.
The general health check-up project of 3.2 safety indexes (body temperature, breathing, pulse, blood pressure), hematuria stool routine, darling renal function inspection etc., to begin a project all before medication and terminate rear each inspection each course for the treatment of once, observe untoward reaction at any time.
4 criterions of therapeutical effect and therapeutic outcome.
" Chinese medical disease Standardization of diagnosis and curative effect " that 4.1 standards are promulgated with reference to State Administration of Traditional Chinese Medicine for 2012 determines following standard: criterion of cure can independently be walked about for patient need not lean on crutch completely, walk with firm steps, can more clear dialogue, memory is recovered better, upper limb is strong, hand held object ability strengthens greatly, and life reaches self-care completely; Effective standard is for after taking 3 courses for the treatment of, and the state of an illness is effectively improved, and walks, speaks, the obstacle such as affective interaction disappears substantially, substantially no longer have sequela, can be engaged in simple housework.
4.2 liang of group patient comparitive study, in table 1.
As seen from Table 1, in the routine patient for the treatment of group 50, cure 35 examples, effective 12 examples, invalid 3 examples, total effective rate is 94%; In the routine patient of matched group 50, cure 23 examples, effective 12 examples, invalid 15 examples, total effective rate is 70%.
Table 1 liang group patient comparitive study.
| Group | Cure | Effectively | Invalid | Total effective rate |
| Treatment group (50) | 35 | 12 | 3 | 94% |
| Matched group (30) | 23 | 12 | 15 | 70% |
4.3 safety indexes are observed.
Before and after this clinical observation treatment, two groups of general health check-up projects of patient, the inspection of hematuria stool routine, cardiac inspections etc. have no significant change.Viewing duration, two groups there is not serious adverse events during this clinical observation, and before and after treatment, hepatic and renal function and routine blood test index of correlation are all without significant difference.
Visible, Western medicine coordinates Chinese medicine of the present invention more can significantly improve the curative effect of hemiplegia than simple doctor trained in Western medicine Primary Care, and there is not side effect, and patient compliance is good, has actual clinical meaning.
Claims (7)
1. treat the Chinese medicine of hemiplegia for one kind, it is characterized in that the medicament be made up of the raw material of following weight proportion: Radix Ginseng 20-40 part, Radix Astragali 40-60 part, Radix Angelicae Sinensis 10-20 part, Radix Paeoniae Alba 10-20 part, Poria 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Radix Glycyrrhizae 3-7 part, Radix Rehmanniae Preparata 40-60 part, Rhizoma Chuanxiong 10-20 part, Cortex Cinnamomi 8-12 part, Rhizoma Pinelliae 8-12 part, Radix Aconiti Lateralis Preparata 8-12 part, Fructus Psoraleae 3-7 part, Radix Ophiopogonis 40-60 part, Fructus Amomi 8-12 part, Cortex Moutan 10-20 part, Radix Bupleuri 5-15 part, Sucus Zingberis 10-20 part, Rhizoma Arisaematis 8-12 part, save prosperous fore-telling 5-15 part, Semen Ziziphi Spinosae 10-20 part, Pericarpium Citri Reticulatae 5-15 part, Radix Linderae 5-15 part, Radix Stephaniae Tetrandrae 3-7 part, Radix Aucklandiae (Radix Vladimiriae) 5-15 part, Lignum Aquilariae Resinatum 8-12 part is made.
2. the Chinese medicine for the treatment of hemiplegia as claimed in claim 1, it is characterized in that the medicament be made up of the raw material of following weight proportion: Radix Ginseng 25-35 part, Radix Astragali 45-55 part, Radix Angelicae Sinensis 12-18 part, Radix Paeoniae Alba 12-18 part, Poria 23-27 part, Rhizoma Atractylodis Macrocephalae 23-27 part, Radix Glycyrrhizae 4-6 part, Radix Rehmanniae Preparata 45-55 part, Rhizoma Chuanxiong 12-18 part, Cortex Cinnamomi 9-11 part, Rhizoma Pinelliae 9-11 part, Radix Aconiti Lateralis Preparata 9-11 part, Fructus Psoraleae 4-6 part, Radix Ophiopogonis 45-55 part, Fructus Amomi 9-11 part, Cortex Moutan 13-17 part, Radix Bupleuri 8-12 part, Sucus Zingberis 12-18 part, Rhizoma Arisaematis 9-11 part, save prosperous fore-telling 8-12 part, Semen Ziziphi Spinosae 12-18 part, Pericarpium Citri Reticulatae 7-13 part, Radix Linderae 7-13 part, Radix Stephaniae Tetrandrae 4-6 part, Radix Aucklandiae (Radix Vladimiriae) 7-13 part, Lignum Aquilariae Resinatum 9-11 part is made.
3. the Chinese medicine for the treatment of hemiplegia as claimed in claim 1, it is characterized in that the medicament be made up of the raw material of following weight proportion: Radix Ginseng 30 parts, the Radix Astragali 50 parts, Radix Angelicae Sinensis 15 parts, the Radix Paeoniae Alba 15 parts, 25 parts, Poria, the Rhizoma Atractylodis Macrocephalae 25 parts, 5 parts, Radix Glycyrrhizae, 50 parts, Radix Rehmanniae Preparata, Rhizoma Chuanxiong 15 parts, Cortex Cinnamomi 10 parts, the Rhizoma Pinelliae 10 parts, Radix Aconiti Lateralis Preparata 10 parts, Fructus Psoraleae 5 parts, Radix Ophiopogonis 50 parts, Fructus Amomi 10 parts, Cortex Moutan 15 parts, Radix Bupleuri 10 parts, Sucus Zingberis 15 parts, Rhizoma Arisaematis 10 parts, save prosperous fore-telling 10 parts, Semen Ziziphi Spinosae 15 parts, Pericarpium Citri Reticulatae 10 parts, the Radix Linderae 10 parts, Radix Stephaniae Tetrandrae 5 parts, Radix Aucklandiae (Radix Vladimiriae) 10 parts, Lignum Aquilariae Resinatum 10 parts is made.
4., as the Chinese medicine of the treatment hemiplegia as described in arbitrary in claim 1-3, it is characterized in that: described medicament is said dosage form on any one pharmaceutics.
5. the Chinese medicine for the treatment of hemiplegia as claimed in claim 4, is characterized in that: described medicament is powder or block agent.
6. described in claim 5, treat the preparation method of the Chinese medicine of hemiplegia, it is characterized in that: first by the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, save prosperous fore-telling, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum mixes by part, add water and decoct 2-4 time, decoct 1-3h at every turn, the decocting liquid of difference gained is merged, filter, be concentrated into the thick paste that relative density is 1.2-2, add Radix Ginseng again, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae soaks, dry, be crushed to granularity and be no more than 400 object powders.
7. preparation method as claimed in claim 6, it is characterized in that: first by the Radix Astragali, the Radix Paeoniae Alba, Poria, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Radix Rehmanniae Preparata, Rhizoma Chuanxiong, Cortex Cinnamomi, the Rhizoma Pinelliae, Radix Aconiti Lateralis Preparata, Fructus Psoraleae, Radix Ophiopogonis, Cortex Moutan, Radix Bupleuri, Sucus Zingberis, Rhizoma Arisaematis, save prosperous fore-telling, Pericarpium Citri Reticulatae, the Radix Linderae, Radix Stephaniae Tetrandrae, Radix Aucklandiae (Radix Vladimiriae), Lignum Aquilariae Resinatum mixes by part, add water and decoct 3 times, decoct 2h at every turn, the decocting liquid of difference gained is merged, filter, be concentrated into the thick paste that relative density is 1.3-1.9, add Radix Ginseng again, Radix Angelicae Sinensis, Fructus Amomi, Semen Ziziphi Spinosae carries out immersion 0.5h-2h, dry, be crushed to granularity and be no more than 400 object powders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410495980.7A CN104208643B (en) | 2014-09-25 | 2014-09-25 | It is a kind of to treat Chinese medicine of hemiplegia and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410495980.7A CN104208643B (en) | 2014-09-25 | 2014-09-25 | It is a kind of to treat Chinese medicine of hemiplegia and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104208643A true CN104208643A (en) | 2014-12-17 |
| CN104208643B CN104208643B (en) | 2017-09-12 |
Family
ID=52090816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410495980.7A Active CN104208643B (en) | 2014-09-25 | 2014-09-25 | It is a kind of to treat Chinese medicine of hemiplegia and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104208643B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943960A (en) * | 2016-06-06 | 2016-09-21 | 陈中元 | Drug for treating male right hemiplegia and preparing method thereof |
| CN106039186A (en) * | 2016-06-06 | 2016-10-26 | 陈中元 | Medicine for treating left hemiplegia of women and preparation of medicine |
| CN107308421A (en) * | 2017-05-08 | 2017-11-03 | 英山县人民医院 | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae |
| CN109846973A (en) * | 2019-03-08 | 2019-06-07 | 顾友琼 | The Chinese medicine composition for preventing and treating facioplegia |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004013107A1 (en) * | 2002-08-05 | 2004-02-12 | Mitsubishi Pharma Corporation | Drugs for preventing and/or treating spinal injury |
| CN101450203A (en) * | 2007-12-05 | 2009-06-10 | 吴彦勇 | Oral liquid for treating hemiplegia |
-
2014
- 2014-09-25 CN CN201410495980.7A patent/CN104208643B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004013107A1 (en) * | 2002-08-05 | 2004-02-12 | Mitsubishi Pharma Corporation | Drugs for preventing and/or treating spinal injury |
| CN101450203A (en) * | 2007-12-05 | 2009-06-10 | 吴彦勇 | Oral liquid for treating hemiplegia |
Non-Patent Citations (4)
| Title |
|---|
| （明）周之干: "《周慎斋医学全书》", 31 May 2010, 海南出版社 * |
| （清）陈士铎: "《辨证录》", 30 June 2005, 第二军医大学出版社 * |
| 梅楠: "偏瘫康复汤治疗中风后遗症55例", 《河南医药信息》 * |
| 王和鸣: "《中国骨伤科学 卷九 骨关节痹瘘病学》", 31 October 1988, 广西科学技术出版社 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943960A (en) * | 2016-06-06 | 2016-09-21 | 陈中元 | Drug for treating male right hemiplegia and preparing method thereof |
| CN106039186A (en) * | 2016-06-06 | 2016-10-26 | 陈中元 | Medicine for treating left hemiplegia of women and preparation of medicine |
| CN107308421A (en) * | 2017-05-08 | 2017-11-03 | 英山县人民医院 | A kind of Chinese medicine composition for treating blood stagnancy due to deficiency of QI type apoplexy sequelae |
| CN109846973A (en) * | 2019-03-08 | 2019-06-07 | 顾友琼 | The Chinese medicine composition for preventing and treating facioplegia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104208643B (en) | 2017-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104208643A (en) | Chinese medicine for treating hemiplegia and preparation method thereof | |
| CN103495019B (en) | A kind of tranquilizing by nourishing the heart Chinese medicine preparation and preparation method thereof | |
| CN105079551A (en) | Traditional Chinese medicine composition for treating edema | |
| CN103768324A (en) | Traditional Chinese medicine composition for treating hand and foot cold | |
| CN106266759A (en) | A kind of granule for apoplexy sequela and rheumatic and rheumatoid diseases and preparation method thereof | |
| CN103536849B (en) | Medicine for the treatment of pulmonary infarction and preparation method thereof | |
| CN102716409A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN104815232A (en) | Traditional Chinese medicine preparation for treating primary pulmonary hypertension and preparation method thereof | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103638234A (en) | Traditional Chinese medicine composition for treating tinnitus, preparation and preparation method thereof | |
| CN104337909B (en) | A kind of Chinese medicine composition of the treatment gout containing Aspongopus | |
| CN103251861A (en) | Traditional Chinese medicine composition for treating headache | |
| CN103083632B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
| CN104888133A (en) | Traditional Chinese medicine composition for treatment of coronary heart disease | |
| CN104758588A (en) | Traditional Chinese medicine composition for treating dizziness | |
| CN108853340A (en) | A kind of Chinese medicine of nourishing the liver and kidney and preparation method thereof | |
| CN103948880B (en) | Traditional Chinese medicine for treating arrhythmia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN103028105B (en) | Traditional Chinese medicine composition for treating headache | |
| CN114504635B (en) | Chinese patent medicine for treating apoplexy sequela | |
| CN106344680A (en) | Traditional Chinese medicinal composition with effects of expelling wind and relieving cold-aggravated arthralgia and preparation method thereof | |
| CN105106786A (en) | Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition | |
| CN105687899A (en) | Traditional Chinese medicine composition for treating senile plaques | |
| CN106214870A (en) | A kind of lavipeditum powder treating rheumatic arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |